Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 2
2012 3
2013 6
2014 6
2015 4
2016 3
2017 3
2018 6
2019 4
2020 3
2021 2
2022 5
2023 5
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Treatment outcomes and safety in children with rifampicin-resistant TB.
Lopez-Varela E, Garcia-Prats AJ, Seddon JA, Draper HR, Winckler J, van der Laan L, Palmer M, Burger WA, Schaaf HS, Hesseling AC. Lopez-Varela E, et al. Among authors: draper hr. Int J Tuberc Lung Dis. 2022 Feb 1;26(2):133-141. doi: 10.5588/ijtld.21.0476. Int J Tuberc Lung Dis. 2022. PMID: 35086625 Free article.
Optimizing dosing of the cycloserine pro-drug terizidone in children with rifampicin-resistant tuberculosis.
van der Laan LE, Garcia-Prats AJ, McIlleron H, Abdelwahab MT, Winckler JL, Draper HR, Wiesner L, Schaaf HS, Hesseling AC, Denti P. van der Laan LE, et al. Among authors: draper hr. Antimicrob Agents Chemother. 2023 Dec 14;67(12):e0061123. doi: 10.1128/aac.00611-23. Epub 2023 Nov 16. Antimicrob Agents Chemother. 2023. PMID: 37971239 Free PMC article.
Population Pharmacokinetics and Dosing of Ethionamide in Children with Tuberculosis.
Bjugård Nyberg H, Draper HR, Garcia-Prats AJ, Thee S, Bekker A, Zar HJ, Hooker AC, Schaaf HS, McIlleron H, Hesseling AC, Denti P. Bjugård Nyberg H, et al. Among authors: draper hr. Antimicrob Agents Chemother. 2020 Feb 21;64(3):e01984-19. doi: 10.1128/AAC.01984-19. Print 2020 Feb 21. Antimicrob Agents Chemother. 2020. PMID: 31871093 Free PMC article.
High Incidence of Tuberculosis Infection in HIV-exposed Children Exiting an Isoniazid Preventive Therapy Trial.
Cranmer LM, Draper HR, Mandalakas AM, Kim S, McSherry G, Krezinski E, Coetzee J, Mitchell C, Nachman S, van der Linde M, Cotton MF, Hesseling AC; IMPAACT P1041 Team. Cranmer LM, et al. Among authors: draper hr. Pediatr Infect Dis J. 2018 Oct;37(10):e254-e256. doi: 10.1097/INF.0000000000001946. Pediatr Infect Dis J. 2018. PMID: 29462104 Free PMC article. Clinical Trial.
Pharmacokinetics and safety of high-dose rifampicin in children with TB: the Opti-Rif trial.
Garcia-Prats AJ, Svensson EM, Winckler J, Draper HR, Fairlie L, van der Laan LE, Masenya M, Schaaf HS, Wiesner L, Norman J, Aarnoutse RE, Karlsson MO, Denti P, Hesseling AC. Garcia-Prats AJ, et al. Among authors: draper hr. J Antimicrob Chemother. 2021 Nov 12;76(12):3237-3246. doi: 10.1093/jac/dkab336. J Antimicrob Chemother. 2021. PMID: 34529779 Free PMC article. Clinical Trial.
53 results